Computer modeling confirmed the weight-based dosing strategy for Daybue (trofinetide) to treat people with Rett syndrome, ages 2 to 20.
Computer modeling confirmed the weight-based dosing strategy for Daybue (trofinetide) to treat people with Rett syndrome, ages 2 to 20.